BioSpace News Archive

Avadel Pharmaceuticals plc (Nasdaq: AVDL) announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Monday, August 10, 2020, to provide a corporate update and discuss the Company’s financial results for the second quarter ended June 30, 2020. To access the conference call, investors are invited to dial 877-407-9716 (U.S. and Canada) or 201-493-6779 (international). The conference ID number is 13707645. A live au

Med PPE Canada Inc., - Med PPE Canada is a personal protective equipment supply company, established in early 2020 to help provide Canadians with a reliable source of PPE during and after the COVID-19 pandemic.

Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or “Company”), a biotechnology company developing novel therapeutics for the treatment of unmet medical needs, today announced receipt of guidance from the U.S. Food and Drug Administration (FDA) on the Company’s recently-filed Investigational New Drug (IND) application

OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended June 30, 2020, as well as discuss financial guidance, after the close of the U.S. financial markets on Thursday, July 30, 2020. OPKO’s senior management will provide a business update and discuss results in greater detail during a conference call and live audio webcast on July 30 beginning at 4:45 p.m. Eastern time. CONFERENCE CALL & WEBCA

WishBone Medical, a pediatric orthopedic company focused on innovative solutions designed around the unmet needs of children, announces a national agreement with Vizient, Inc., the largest member-driven health care performance improvement company in the United States. The agreement provides anatomically appropriate orthopedic solutions for arms, legs, spine, elbows, wrists and clavicles to surgeons caring for children. “In the year 2020, ther

Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics™), today announced the appointment of Andrew Joe, M.D., as Chief Medical Officer. Dr. Joe is a medical oncologist with extensive expertise in the development of immuno-oncology, antibody and targeted cancer therapies, and with broad leadership experience in oncolog

Todos Medical Ltd. (OTCQB: TOMDF) , an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced the Company has entered into a contract to supply NJ-based laboratory Best Suppl

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, will report second quarter 2020 financial results after the Nasdaq Global Market close on Monday, August 10, 2020. About Catabasis At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing therapies to patients

Transformative, a healthcare startup whose software predicts sudden cardiac arrest, announced that it has raised a $1.7 million seed round, led by Tera Ventures.

Bruker Corporation announced the launch of the FluoroType® SARS-CoV-2 plus next-generation 6-plex PCR assay for the highly specific detection of the SARS-CoV-2 virus, which causes the respiratory and systemic disease COVID-19.